- ¥329bn
- ¥277bn
- ¥251bn
- 85
- 58
- 92
- 94
Annual balance sheet for Ulvac, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
| 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho | 
| Standards: | JAS | JAS | JAS | JAS | JAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 91,545 | 118,040 | 98,399 | 96,334 | 105,951 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 65,970 | 85,806 | 83,017 | 102,789 | 84,313 | 
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 202,530 | 263,847 | 255,280 | 278,846 | 270,077 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 66,086 | 64,995 | 69,588 | 79,745 | 76,920 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 292,761 | 354,304 | 353,474 | 388,653 | 375,062 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 77,819 | 116,762 | 106,754 | 116,378 | 100,655 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 125,862 | 165,328 | 155,262 | 168,223 | 151,597 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 166,899 | 188,976 | 198,212 | 220,430 | 223,465 | 
| Total Liabilities & Shareholders' Equity | 292,761 | 354,304 | 353,474 | 388,653 | 375,062 | 
| Total Common Shares Outstanding |